A Shared Passion for Impactful Science

Surge's mission is to shape the future of precision medicine by decrypting the immune system.

Brice Gaudilliere, an expert in human immunology and single-cell omics technologies and Julien Hedou, an expert in biomedical informatics and machine learning.
‍
A physician scientist and principal investigator, Brice had been applying single-cell omics technologies to study the human immune response to physiological stressors, such as surgery, when Julien Hedou joined his laboratory to develop rigorous statistical methods for the analysis of large and complex biological datasets.

They assembled a team with combined expertise and shared values of scientific rigor, patient-centered approaches, value-based care, and translational medicine and accelerated this field, leading to the launch of Surge.

Our Mission

Governance

Scientific & Clinical Advisory Board

In addition to our team of founders, investors, representatives, and independent experts in the field, Surge has a Scientific and Clinical Advisory Board to rigorously advance our technology to enable personalized care.

Franck Verdonk ^{MD, PhD}

An Associate Professor of Anesthesiology & Intensive Care at Sorbonne University Chairs the Scientific Board.

Dyani Jones ^{DMD, MPH}

Clinical Associate Professor of Surgery at Stanford University.

Brice Gaudilliere ^{MD, PhD}

Associate Professor of Anesthesiology, Perioperative & Pain Medicine at Stanford University.

Discover PreCyte products

Meet Our Team

Surge is a Stanford spin-off, founded in 2021. We are physicians, immunologists, and AI engineers who share one conviction: the immune system holds answers that patients need and reaching them takes both scientific rigor and genuine care.

Our work sits at the meeting point of medicine, immunology, and AI, and we carry it all the way from fundamental research to the patient's bedside.